Literature DB >> 9842104

Body composition and long-term levo-carnitine supplementation.

G M Trovato1, E Iannetti, A M Murgo, G Carpinteri, D Catalano.   

Abstract

PURPOSE: To evaluate the effect of long-term levocarnitine supplementation on nutritional state of patients in maintenance dialysis. PATIENTS AND METHODS: We studied by multifrequency-BIA (bioelectric impedance analysis) two groups of patients in maintenance bicarbonate hemodialysis for at least 4 years, comparable with respect to gender and age, and without liver disease, diabetes and malignancy. One group (25 patients) was treated with levocarnitine (1g/die) for three years or more; the control group (35 patients) never received this agent.
RESULTS: Long-term levocarnitine supplementation was associated with higher serum levels of total protein and albumin in comparison to the control group. These effects were not associated with an increase in body fat mass and/or in total body water content, which are potentially detrimental conditions, especially considering the reported frequent association with circulatory and blood pressure alterations.
CONCLUSIONS: Levocarnitine is able to improve the nutritional state, and this is associated with higher protein catabolism rate, i.e. with a higher protein intake, without detrimental effects on dialysis efficacy and adequacy.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9842104

Source DB:  PubMed          Journal:  Clin Ter        ISSN: 0009-9074


  7 in total

1.  Hemodynamic stabilizing effects of L-carnitine in chronic hemodialysis patients.

Authors:  Y Kudoh; S Aoyama; T Torii; Q Chen; D Nagahara; H Sakata; A Nozawa
Journal:  Cardiorenal Med       Date:  2013-09-27       Impact factor: 2.041

2.  Levocarnitine Injections Decrease the Need for Erythropoiesis-Stimulating Agents in Hemodialysis Patients with Renal Anemia.

Authors:  Takashi Maruyama; Terumi Higuchi; Toshio Yamazaki; Erina Okawa; Hideyuki Ando; Osamu Oikawa; Atsushi Inoshita; Kazuyoshi Okada; Masanori Abe
Journal:  Cardiorenal Med       Date:  2017-04-20       Impact factor: 2.041

3.  Carnitine supplementation improves cardiac strain rate in children on chronic hemodialysis.

Authors:  Kristen Sgambat; Lowell Frank; Ahmad Ellini; Craig Sable; Asha Moudgil
Journal:  Pediatr Nephrol       Date:  2012-03-22       Impact factor: 3.714

Review 4.  Effect of L-carnitine therapy on patients in maintenance hemodialysis: a systematic review and meta-analysis.

Authors:  Shi-Kun Yang; Li Xiao; Pan-Ai Song; Xiaoxuan Xu; Fu-You Liu; Lin Sun
Journal:  J Nephrol       Date:  2013-12-17       Impact factor: 3.902

Review 5.  Significance of Levocarnitine Treatment in Dialysis Patients.

Authors:  Hiroyuki Takashima; Takashi Maruyama; Masanori Abe
Journal:  Nutrients       Date:  2021-04-07       Impact factor: 5.717

6.  Effect of levocarnitine supplementation on myocardial strain in children with acute kidney injury receiving continuous kidney replacement therapy: a pilot study.

Authors:  Kristen Sgambat; Sarah Clauss; Asha Moudgil
Journal:  Pediatr Nephrol       Date:  2021-01-03       Impact factor: 3.714

7.  Kinetics of carnitine concentration after switching from oral administration to intravenous injection in hemodialysis patients.

Authors:  Anna Suzuki; Yukinao Sakai; Kazumasa Hashimoto; Hirokazu Osawa; Shuichi Tsuruoka
Journal:  Ren Fail       Date:  2018-11       Impact factor: 2.606

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.